Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53

Abstract

The p53 gene is a tumor suppressor that regulates the expression of genes required for cell cycle arrest or apoptosis. Mutations in p53 have been observed in over 60% of all human cancers. Certain classes of mutant p53 proteins maintain some of their activities or acquire novel activities and thus may contribute to the transformed phenotype. By carrying out an analysis of differential gene expression using cDNA expression arrays, we compared the expression patterns of cells expressing no p53 to isogenic lines expressing the codon 248 Arg to Trp mutant p53 allele (R248W). In this report, we show that the R248W and D281G p53 mutants, two of the more commonly occurring mutations, as well as wild type p53, repress transcription of the tissue inhibitor of metalloproteinases type 3 (TIMP-3) gene by greater than tenfold. TIMP-3 expression has been observed to be repressed in many tumors and its reduced expression is thought to contribute to tumor metastasis and invasiveness by allowing increased activity of metalloproteinases in the extracellular matrix. Since mutant forms of p53 tend to be expressed at greatly elevated levels in many human tumors, the retention of their ability to repress TIMP-3 illustrate one mechanism by which mutant forms of the p53 gene may contribute to tumorigenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Agoff SN, Hou J, Linzer DI and Wu B. . 1993 Science 259: 84–87.

  • Ahonen M, Baker AH and Kahari VM. . 1998 Cancer Res. 58: 2310–2315.

  • Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B and Apte SS. . 1996 Biochem. Cell. Biol. 74: 853–862.

  • Andreu T, Beckers T, Thoenes E, Hilgard P and von Melchner H. . 1998 J. Biol. Chem. 273: 13848–13854.

  • Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS and Kelly K. . 1997 Cell 89: 1175–1184.

  • Baker AH, Zaltsman AB, George SJ and Newby AC. . 1998 J. Clin. Invest. 101: 1478–1487.

  • Balint E and Reisman D. . 1996 Cancer Res. 56: 1648–1653.

  • Barak Y, Juven T, Haffner R and Oren M. . 1993 EMBO J. 12: 461–468.

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. . 1998 Nature 395: 124–125.

  • BenEzra D. . 1997 Invest. Ophthalmol. Vis. Sci. 38: 2433–2434.

  • Bian J, Jacobs C, Wang Y and Sun Y. . 1996 Carcinogenesis 17: 2559–2562.

  • Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, Kung HF, Colburn NH and Sun Y. . 1996 Carcinogenesis 17: 1805–1811.

  • Blandino G, Levine AJ and Oren M. . 1999 Oncogene 18: 477–485.

  • Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP and Cheresh DA. . 1996 Cell 85: 683–693.

  • Budde A and Grummt I. . 1999 Oncogene 18: 1119–1124.

  • Cairns CA and White RJ. . 1998 EMBO J. 17: 3112–3123.

  • Chan EC, Lue MY, Hsu KC and Fan HA. . 1998 Biochim. Biophys. Acta. 1407: 200–204.

  • Chen PL, Chen YM, Bookstein R and Lee WH. . 1990 Science 250: 1576–1580.

  • Chin KV, Ueda K, Pastan I and Gottesman MM. . 1992 Science 255: 459–462.

  • Cho Y, Gorina S, Jeffrey PD and Pavletich NP. . 1994 Science 265: 346–355.

  • Deb S, Jackson CT, Subler MA and Martin DW. . 1992 J. Virol. 66: 6164–6170.

  • Di Como CJ, Gaiddon C and Prives C. . 1999 Mol. Cell. Biol. 19: 1438–1449.

  • Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. . 1993 Nat. Genet. 4: 42–46.

  • el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. . 1992 Nat. Genet. 1: 45–49.

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A and Oren M. . 1999 Mol. Cell. Biol. 19: 2594–2600.

  • Farmer G, Colgan J, Nakatani Y, Manley JL and Prives C. . 1996 Mol. Cell. Biol. 16: 4295–4304.

  • Farmer G, Friedlander P, Colgan J, Manley JL and Prives C. . 1996 Nucleic Acids Res. 24: 4281–4288.

  • Fearon ER and Vogelstein B. . 1990 Cell 61: 759–767.

  • Foley J, Wysolmerski JJ, Broadus AE and Philbrick WM. . 1996 Cancer Res. 56: 4056–4062.

  • Frazier MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP. . 1998 Mol. Cell. Biol. 18: 3735–3743.

  • Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. . 1992 Mol. Cell. Biol. 12: 2866–2871.

  • Gerwin BI, Spillare E, Forrester K, Lehman TA, Kispert J, Welsh JA, Pfeifer AM, Lechner JF, Baker SJ, Vogelstein B et al. 1992 Proc. Natl. Acad. Sci. USA 89: 2759–2763.

  • Giaccia AJ and Kastan MB. . 1998 Genes Dev. 12: 2973–2983.

  • Ginsberg D, Mechta F, Yaniv M and Oren M. . 1991 Proc. Natl. Acad. Sci. USA 88: 9979–9983.

  • Gomez DE, Alonso DF, Yoshiji H and Thorgeirsson UP. . 1997 Eur. J. Cell. Biol. 74: 111–122.

  • Gu W, Shi XL and Roeder RG. . 1997 Nature 387: 819–823.

  • Gualberto A, Aldape K, Kozakiewicz K and Tlsty TD. . 1998 Proc. Natl. Acad. Sci. USA 95: 5166–5171.

  • Gualberto A, Hixon ML, Finco TS, Perkins ND, Nabel GJ and Baldwin Jr AS. . 1995 Mol. Cell. Biol. 15: 3450–3459.

  • Harvey DM and Levine AJ. . 1991 Genes Dev. 5: 2375–2385.

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW and Vogelstein B. . 1997 Mol. Cell. Biol. 1: 3–11.

  • Hiraoka N, Allen E, Apel IJ, Gyetko MR and Weiss SJ. . 1998 Cell 95: 365–377.

  • Horikoshi N, Usheva A, Chen J, Levine AJ, Weinmann R and Shenk T. . 1995 Mol. Cell. Biol. 15: 227–234.

  • Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. . 1994 Am. J. Pathol. 145: 702–714.

  • Hsiao M, Wu CY, Low J, Pattengale P, Yeargin J and Haas M. . 1995 Mol. Carcinog. 13: 112–121.

  • Hussain SP and Harris CC. . 1998 Cancer Res. 58: 4023–4037.

  • Jackson P, Bos E and Braithwaite AW. . 1993 Oncogene 8: 589–597.

  • Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr, AJ. . 1992 Cell 71: 587–597.

  • Kim H, Pennie WD, Sun Y and Colburn NH. . 1997 Biochem. J. 324: 547–553.

  • Kinzler KW and Vogelstein B. . (1998) In: Colorectal tumors. The Genetic Basis Of Human Cancer. Vogelstein B and Kinzler KW. (eds.).. McGraw-Hill: New York pp. 565–587.

    Google Scholar 

  • Leco KJ, Khokha R, Pavloff N, Hawkes SP and Edwards DR. . 1994 J. Biol. Chem. 269: 9352–9360.

  • Lee KC, Crowe AJ and Barton MC. . 1999 Mol. Cell. Biol. 19: 1279–1288.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M and Welsh D. . 1994 Br. J. Cancer 69: 409–416.

  • Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M and Rotter V. . 1998 Oncogene 16: 3269–3277.

  • Lill J, Teresky AK and Levine AJ. . 1995 Oncogene 10: 2387–2390.

  • Lu H and Levine AJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 5154–5158.

  • Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP and Deb S. . 1996 Mol. Cell. Biol. 16: 6009–6019.

  • Mack DH, Vartikar J, Pipas JM and Laimins LA. . 1993 Nature 363: 281–283.

  • Miyashita T and Reed JC. . 1995 Cell 80: 293–299.

  • Muller BF, Paulsen D and Deppert W. . 1996 Oncogene 12: 1941–1952.

  • Murphy M, Hinman A and Levine AJ. . 1996 Genes Dev. 10: 2971–2980.

  • Okamoto K and Beach D. . 1994 EMBO J. 13: 4816–4822.

  • Pennie WD, Hegamyer GA, Young MR and Colburn NH. . 1999 Cell Growth Differ. 10: 279–286.

  • Prives C. . 1998 Cell 95: 5–8.

  • Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M and Aloni Y. . 1993 Oncogene 8: 1183–1193.

  • Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. . 1996 EMBO J. 15: 827–838.

  • Ryan KM and Vousden KH. . 1998 Mol. Cell. Biol. 18: 3692–3698.

  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M. . 1994 Nature 370: 61–65.

  • Schwartz D and Rotter V. . 1998 Semin. Cancer Biol. 8: 325–336.

  • Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ and Shenk T. . 1992 Proc. Natl. Acad. Sci. USA 89: 12028–12032.

  • Shaulsky G, Goldfinger N and Rotter V. . (1991) Cancer Res. 51: 5232–5237.

  • Sherr CJ. . 1998 Genes Dev. 12: 2984–2991.

  • Shohat O, Greenberg M, Reisman D, Oren M and Rotter V. . 1987 Oncogene 1: 277–283.

  • Smith MR, Kung H, Durum SK, Colburn NH and Sun Y. . 1997 Cytokine 9: 770–780.

  • Subler MA, Martin DW and Deb S. . 1992 J. Virol. 66: 4757–4762.

  • Sun Y, Hegamyer G and Colburn NH. . 1994 Cancer Res. 54: 1139–1144.

  • Sun Y, Hegamyer G, Kim H, Sithanandam K, Li H, Watts R and Colburn NH. . 1995 J. Biol. Chem. 270: 19312–19319.

  • Sun Y, Nakamura K, Wendel E and Colburn N. . 1993 Proc. Natl. Acad. Sci. USA 90: 2827–2831.

  • Thut CJ, Chen JL, Klemm R and Tjian R. . 1995 Science 267: 100–104.

  • Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M and Okada Y. . 1997 Cancer Res. 57: 2055–2060.

  • Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJS, Friedmann T, Detribolet N and Cavenee WK. . 1994 Cancer Res. 54: 649–652.

  • Vassalli JD and Pepper MS. . 1994 Nature 370: 14–15.

  • Wang Q, Zambetti GP and Suttle DP. . 1997 Mol. Cell. Biol. 17: 389–397.

  • Werb Z. . 1997 Cell 91: 439–442.

  • Will K, Warnecke G, Wiesmuller L and Deppert W. . 1998 Proc. Natl. Acad. Sci. USA 95: 13681–13686.

  • Woessner Jr JF. . 1991 FASEB J., 5: 2145–2154.

  • Xiao H, Pearson A, Coulombe B, Truant R, Zhang S, Regier JL, Triezenberg SJ, Reinberg D, Flores O, Ingles CJ et al. . 1994 Mol. Cell. Biol. 14: 7103–7024.

  • Yew PR, Liu X and Berk AJ. . 1994 Genes Dev. 8: 190–202.

  • Yu Q and Stamenkovic I. . 1991 Genes Dev. 13: 35–48.

Download references

Acknowledgements

We thank A Levine for the 10(3) cells and for the R248W and D281G p53 cDNAs, and N Colburn and G Hegamyer for the murine TIMP-3 promoter. We thank our colleagues at the University of South Carolina for discussions and comments on the manuscript. Supported by grants from the American Cancer Society and the NIH.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loging, W., Reisman, D. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53. Oncogene 18, 7608–7615 (1999). https://doi.org/10.1038/sj.onc.1203135

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203135

Keywords

This article is cited by

Search

Quick links